Our managers will contact you as soon as possible.
“Amilar ІC” – a combined drug for sore throat treatment, which includes a broad-spectrum antiseptic dequalinium chloride and a local anesthetic – dibucaine.
On the market “Amilar ІC” is available in three flavor varieties: with mint, cherry and orange flavor.
The drug is indicated for the treatment of acute infectious and inflammatory diseases of the mouth and throat, as gingivitis, ulcerative and aphthous stomatitis, tonsillitis, laryngitis and pharyngitis; in mixed infections of the mouth and throat. As an auxiliary drug “Amilar ІC” can be taken at catarrhal and lacunar angina, angina Plaut – Vincent, as well as candidiasis of the oral cavity and pharynx.
Local anesthetizing and bactericidal action of the preparation allows to use it in the postoperative period after removal of the tonsils or teeth. “Amilar ІC” eliminates pain after surgery and does not allow to develop infectious complications. In addition, an antimicrobial and fungistatic activity of “Amilar ІC” make it usesful in helping to get rid of bad breath.
Antiseptic effect of “Amilar ІC” applies to most gram-positive and gram-negative bacteria as well as spirochetes and fungi (in particular the genus Candida) causing the mixed-infectious inflammatory diseases of the oral cavity and pharynx. “Amilar ІC” shows a slight local anesthetic effect, so that the drug is not only struggling with microbes, but also eases the pain syndrome, which is a frequent companion of most infectious and inflammatory diseases of the oral cavity and pharynx.
Despite the wide range of actions, that make up the components of the preparation, it has only a local effect and does not enter the systemic circulation, and hence – have no effect on the entire body. In addition, “Amilar ІC” contains no sugar and can be used by patients with diabetes. Due to the lack of sugar, drug do not contribute to the development of caries.
Recent publications

InterChem CEO Anatoliy Reder joined the Ukrainian delegation on a business visit to Riyadh
The purpose of the trip was to strengthen economic cooperation between Ukraine and the Kingdom of Saudi Arabia and to present the capabilities ...

InterChem Among the Top 13 Best Educational Projects in Ukraine
InterChem has been recognized among the Top 13 Best Educational Projects initiated by Ukrainian businesses. Within the national project “Investing in Education”, the ...

InterChem at URC 2025: Signing of the Ukraine–EU Memorandum on Critical Medicines
Anatoliy Reder, CEO of InterChem and official representative of the Association of Ukrainian Medicines Manufacturers (AULM), signed a Memorandum of Cooperation between Ukraine ...

Anatoliy Reder, CEO of InterChem, ranked among Ukraine’s Top 50 CEOs
Anatoliy Reder became the winner in the nomination “Leader in Pharmaceutical Research and Innovation” in Ukraine’s national Top 50 CEOs ranking. The list ...

